Seeking knowledge and expertise to tackle COVID-19
9 April 2020 A new database designed to make it easier for Australian experts to contribute to tackling COVID-19 has been launched, championed by Australia’s Chief Scientist, Dr Alan Finkel. An initiative of the Learned Academies of Australia,…
Melbourne researchers use cutting-edge technology to produce three new COVID-19 vaccine candidates
9 April 2020 Monash University researchers have produced the first known mRNA COVID-19 vaccine candidates in Australia using an advanced technological approach capable of generating vaccines ready for human testing in record time. With the global race to…
AMGC COVID-19 Manufacturer Response Register
9 April 2020 The Advanced Manufacturing Growth Centre have created a register seeking expressions of interest from Australian manufacturers and others looking to assist with supply of goods, services or knowledge during the current COVID-19 outbreak. Visit the…
Immutep’s Partner, EOC Pharma, Continues to Advance Efti in Breast Cancer
8 April 2020 Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), is pleased to inform that EOC Pharma (“EOC”) and Immutep jointly discussed the current AIPAC results and confirmed plans to continue advancing Efti (designated as…
Post-Deployment In Wuhan Hospitals, MUVi Is Now Seeking To Scale-Up UV Light Productions For Australian Healthcare Facilities
7 April 2020 Murray McDonald, the director of Australian MedTech startup MUVi (Mobile UV innovation) is seeking $200K to produce an additional batch of UV lights to supply Australian hospitals. “We are rapidly scaling up our UV lights…
Doherty Institute release COVID-19 modelling papers
7 April 2020 Doherty Institute researchers have released their work on COVID-19 modelling to the general public. These models have been utilised by the Commonwealth Government in the public health response to COVID-19. It’s important to note the modelling is…
A test for COVID-19 risk, infectivity and immunity
7 April 2020 Monash scientists are repurposing technology they developed recently to make a rapid test to determine who: has immunity to coronavirus remains infectious is at risk of developing a severe form of the disease. A team,…
Robert Bosch Australia – Manufacturers FOR Manufacturers
7 April 2020 Posted on behalf of Robert Bosch Australia in regards to COVID-19 assistance: “We are designers and builders of manual to automated manufacturing systems, robotics and testing systems which can be used in the manufacturing of anything…
Global Plasma Leaders Collaborate to Accelerate Development of Potential COVID-19 Hyperimmune Therapy
7 April 2020 Biotest, BPL, LFB, and Octapharma have joined an alliance formed by CSL Behring (ASX:CSL/USOTC:CSLLY) and Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) to develop a potential plasma-derived therapy for treating COVID-19. The alliance will begin immediately with the investigational development of one,…
CSIRO – Nation’s disease response bolstered
4 April 2020 With the increasing threat of diseases spreading from animals to humans, including COVID-19, $220m will be directed to upgrading the high containment biosecurity research facility in Geelong, currently testing vaccines to combat the disease. Operated…
Call for Australian manufacturers to supply COVID-19 test kit components
6 April 2020 Are you an Australian manufacturer with the capability to produce inputs for COVID-19 RNA extraction? Do you have support to scale up your production? We want to hear from you. Securing Australia’s COVID-19 testing capacity…
Possible coronavirus drug identified by Monash University scientists
3 April 2020 A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint venture of the University of Melbourne and Royal Melbourne Hospital, has shown that…
